Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin

Pathology Research and Practice

Volumn 192, Issue 8, 1996, Pages 825-833

  Talve, L ^a   Kainu, J ^b   Collan, Y ^b   Ekfors, T ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Melanoma; Mitotic index; Morphometry; p53; Prognostication

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS INDEX; MORPHOMETRICS; PROGNOSIS; PROTEIN EXPRESSION; THICKNESS;

EID: 0029848629     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80056-2     Document Type: Article

References (33)

1. Akslen LA, Morkve O (1992) Expression of p53 protein in cutaneous melanoma. Int J Cancer 52: 13-16
2. Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B, Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12
3. Barnhill RL, Castresana JS, Rubio M-P, Martin MT, Idoate M, Vazquez JJ, Thor AD (1994) p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent and metastatic melanoma. Modern Pathology 7: 533-535
4. Bártek J, Bártkova J, Vojtesek B, Staskova Z, Lukás J, Reithar A, Kovarik J, Midgley CA, Gannon JV, Lane DP (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6: 1699-1703
5. Campbell C, Quinn AG, Ro Y-S, Angus B, Rees JL (1993) p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100: 746-748
6. Casazza S, Gambini C, Tunesi G, Rovida S, Caruso F, Pastorino A, Canepa M (1993) Expression of p53 protein in cutaneous melanoma. Pathologica 85: 335-342
7. Castresana JS, Rubio MP, Vazquez JJ, Idoate M, Sober AJ, Seizinger BR, Barnhill RL (1993) Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer 55: 562-565
8. Cristofolini M, Boi S, Giralndo S, Zumiani G, Cristofolini P, Dalla Palma P, Doglioni C, Barbareschi M (1993) p53 protein expression in nevi and melanomas. Arch Dermatol 129: 739-743
9. Finlay CA, Hinds PW, Tan T, Eliyahu D, Oren M, Levine A (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8: 531-539
10. Florenes VA, Oyjord T, Holm R, Skrede M, Borresen AL, Nesland JM, Fodstad O (1994) Tp53 allele loss, mutations and expression in malignant melanoma. Br J Cancer 69: 253-259
11. Girod SC, Groth W, Junk M, Gerlach K-L (1994) p53 and PCNA expression in malignant melanomas of the head and neck. Pigment Cell Res 7: 354-357
12. Hall PA, McKee PH, Menage HD, Dover R, Lane DP (1992) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203-207
13. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of the p53 protein in the cellular response to DNA damage. Cancer Research 51: 6304-6311
14. Klemi PJ, Takahashi S, Joensuu H, Kiilholma P, Narimatsu E, Mori M (1994) Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int J Gynecol Pathol 13: 228-233
15. Kronqvist P, Collan Y, Kuopio T, Kujari H (1995) Nuclear morphometry in breast cancer. The influence of sampling rules and freezing of samples. Modern Pathology 8: 187-192
16. Lassam NJ, From L, Kahn HJ (1993) Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Research 53: 2235-2238
17. Lipponen PK (1993) Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 53: 365-370
18. Maxwell SA, Roth JA (1994) Posttranslational regulation of p53 tumor suppressor protein function. Crit Rev Oncogenesis 5: 23-57
19. McGregor JM, Yu CC-W, Dublin EA, Barnes DM, Levison DA, Macdonald DM (1993) p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol 128: 606-611
20. Montano X, Shamsher M, Whitehead P, Dawson K, Newton J (1994) Analysis of p53 in human cutaneous melanoma cell lines. Oncogene 9: 1455-1459
21. Nieminen S, Yli-Jama T, Hietanen T, Ekfors T, Nordman E (1987) The increasing incidence and prognosis of skin melanoma in South Western Finland. Duodecim 103: 1134-1138
22. Ro YS, Cooper PN, Lee JA, Quinn AG, Harrison D, Lane D, Home CHW, Rees JL, Angus B (1993) p53 protein expression in benign and malignant skin tumours. Br J Dermatol 128: 237-241
23. Saenz-Santamaria MC, McNutt NS, Bogdany JK, Shea CR (1995) p53 expression is rare in cutaneous melanomas. Am J Dermatopathol 17: 344-349
24. Shaulsky G, Ben-Ze'ev A, Rotter V (1990) Subcellular distribution of the p53 protein during the cell cycle of Balb/c3T3 cells. Oncogene 5: 1707-1711
25. Stenmark-Askmalm M, Stal O, Sullivan S, Ferraud L, Sun XF, Carstensen J, Nordenskjold B (1994) Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer. Eur J Cancer 30A: 175-180
26. Stretch JR, Gatter KC, Ralfkiaer E, Lane DP, Harris AL (1991) Expression of mutant p53 in melanoma. Cancer Research 51: 5976-5979
27. Ulbright TM, Orazi A, de Riese W, de Riese C, Messemer JE, Foster RS, Donohue JP, Eble JN (1994) The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. Modern Pathology 7: 64-68
28. Volkenandt M, Schlegel U, Nanus DM, Albino AP (1991) Mutational analysis of the human p53 gene in malignant melanoma. Pigment Cell Res 4: 35-40
29. Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC (1993) Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 54: 693-699
30. Weiss J, Heine M, Körner B, Pilch H, Jung EG (1995) Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol 133: 23-31
31. Yamamoto M, Takahashi H (1993) Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin. Virchows Arch (A) 422: 127-132
32. Yamamoto M, Takahashi H, Saitoh K, Horikoshi T, Takahashi M (1995) Expression of the p53 protein in malignant melanomas as a prognostic indicator. Arch Dermatol Res 287: 146-151
33. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelmann J, Remington L, Jacks T, Brash DE (1994) Sunburn and p53 in the onset of skin cancer. Nature 372: 773-776